Barclays PLC Decreases Position in American Well Co. (NYSE:AMWL)

Barclays PLC lowered its stake in American Well Co. (NYSE:AMWL) by 95.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,108 shares of the company’s stock after selling 140,251 shares during the quarter. Barclays PLC’s holdings in American Well were worth $67,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of AMWL. Renaissance Technologies LLC grew its position in American Well by 63.9% in the second quarter. Renaissance Technologies LLC now owns 6,833,500 shares of the company’s stock valued at $2,220,000 after acquiring an additional 2,665,300 shares in the last quarter. AQR Capital Management LLC grew its holdings in American Well by 28.1% during the 2nd quarter. AQR Capital Management LLC now owns 1,895,730 shares of the company’s stock valued at $616,000 after purchasing an additional 416,387 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. grew its stake in shares of American Well by 2,690.2% during the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 419,841 shares of the company’s stock valued at $136,000 after acquiring an additional 404,794 shares in the last quarter. Cubist Systematic Strategies LLC grew its stake in American Well by 7,673.8% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 184,083 shares of the company’s stock valued at $60,000 after purchasing an additional 181,715 shares in the last quarter. Finally, Point72 DIFC Ltd grew its stake in American Well by 1,418.5% during the 2nd quarter. Point72 DIFC Ltd now owns 103,457 shares of the company’s stock valued at $34,000 after purchasing an additional 96,644 shares in the last quarter. 56.05% of the stock is currently owned by hedge funds and other institutional investors.

American Well Stock Performance

Shares of NYSE:AMWL opened at $11.00 on Friday. The company’s fifty day moving average is $8.53 and its two-hundred day moving average is $8.81. American Well Co. has a 1-year low of $5.00 and a 1-year high of $29.00. The stock has a market capitalization of $168.49 million, a price-to-earnings ratio of -0.75 and a beta of 1.11.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Needham & Company LLC reiterated a “hold” rating on shares of American Well in a research note on Thursday, October 31st. Morgan Stanley decreased their price objective on shares of American Well from $20.00 to $10.50 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. Finally, Wells Fargo & Company upgraded shares of American Well from an “equal weight” rating to an “overweight” rating and set a $15.00 target price on the stock in a research note on Monday, January 13th.

American Well Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.